"Remdesivir just as effective against Omicron." We
Post# of 148158
Quote:
Gilead’s remdesivir, Merck’s molnupiravir and Pfizer’s Paxlovid will likely retain their activity against all current variants of concern, including Omicron, as the target proteins of these antivirals are highly conserved, according to results from a new study posted on bioRxiv.
It's the 2nd item down. first section talks about boosters.
https://endpts.com/covid-19-roundup-fda-autho...%20Omicron